The Enterprise Value as of December 2025 (TTM) for Pherecydes Pharma S.A. (ALPHE.PA) is 17.34M

According to Pherecydes Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.34M. This represents a change of -1355.62% compared to the average of -1380786.00 of the last 4 quarters.

Pherecydes Pharma S.A. (ALPHE.PA) Historical Enterprise Value (quarterly & annually)

How has ALPHE.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of Pherecydes Pharma S.A. over the last ten years is 44.63M. The current 17.34M Enterprise Value has changed 3.78% with respect to the historical average. Over the past ten years (40 quarters), ALPHE.PA's Enterprise Value was at its highest in in the December 2022 quarter at 1.50M. The Enterprise Value was at its lowest in in the June 2021 quarter at -5274736.00.

Pherecydes Pharma S.A. (ALPHE.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pherecydes Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pherecydes Pharma S.A. (ALPHE.PA) Average Enterprise Value

How has ALPHE.PA Enterprise Value performed in the past?

The current Enterprise Value of Pherecydes Pharma S.A. (ALPHE.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pherecydes Pharma S.A. (ALPHE.PA) Enterprise Value vs. Peers

How is ALPHE.PA’s Enterprise Value compared to its peers?

Pherecydes Pharma S.A.’s Enterprise Value is greater than TheraVet S.A. (10.03M), greater than Aptorum Group Limited (10.01M), less than Fermentalg S.A. (38.24M), greater than Theradiag S.A. (12.74M), greater than Lysogene S.A. (2.51M), greater than Quantum Genomics S.A. (7.34M), greater than Acticor Biotech SAS (5.93M), greater than PHAXIAM Therapeutics S.A. (3.80M), greater than Hybrigenics S.A. (7.18M), less than Nicox S.A. (30.99M),

Build a custom stock screener for Pherecydes Pharma S.A. (ALPHE.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pherecydes Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pherecydes Pharma S.A. (ALPHE.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pherecydes Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.